Skip to main content

Influenza Pandemic

Volume 464: debated on Monday 15 October 2007

To ask the Secretary of State for Health pursuant to the answer of 25 July 2007, Official Report, column 1223W, on influenza pandemic, whether any of the stockpile of A/H5N1 vaccines have been used; at what cost the stockpile was purchased; and what the shelf-life of the vaccine is. (156749)

None of the current stockpile of H5N1 vaccine has been used. The stockpile was purchased at a cost of £33.4 million. Vaccine from two different manufacturers has been stockpiled. Vaccine from one manufacturer has a shelf life of two years and the vaccine from the other has a shelf life of 12 months, and is subject to on-going stability testing by the National Institute for Biological Standards and Control and the manufacturers.